The FDA has begun soliciting feedback to inform the next version of the Prescription Drug User Fee Act. User fees remain ...

Forty-four subjects received a live attenuated measles virus vaccine. § Twenty-eight received in addition pooled human immune serum globulin in the manufacturer's recommended dose of 0.01 ml. per ...

MASLD has become the most common chronic liver disease worldwide. The authors review the features of the disease as well as pharmacotherapies targeting the associated liver and cardiovascular ...

Risdiplam, an oral pre–messenger RNA splicing modifier, is an efficacious treatment for persons with symptomatic spinal muscular atrophy (SMA). The safety and efficacy of risdiplam in ...

A 28-year-old woman was admitted to the hospital because of severe hypoxemia and right heart failure that had been caused by rapidly progressive pulmonary hypertension. A diagnosis was made.

MENINGITIS during the first month of life is a rare disease. When it occurs, however, early diagnosis is difficult, therapy is uncertain, and the prognosis is still generally stated to be poor.1 , ...

The authors review available data on the benefits and risks of testosterone treatment in middle-aged and older men with moderate hypogonadism.

Plague is a high-consequence infectious disease with epidemic potential. Current treatment guidelines are based on weak evidence. We enrolled persons (excluding pregnant persons) in Madagascar who ...

NEJM uses highly rigorous editorial, peer, and statistical review processes to evaluate manuscripts for scientific accuracy, novelty, and importance.

Semaglutide and cagrilintide have each been shown to induce weight loss, but how these drugs work in combination in patients with type 2 diabetes and overweight or obesity is unknown. New research ...

CME activities, cases, challenges, videos, and more teaching and learning tools from the New England Journal of Medicine.

Quick Take Video Summary from The New England Journal of Medicine — Cagrilintide–Semaglutide in Adults with Overweight or Obesity ...